Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday ...
“This Orphan Drug Designation from the USFDA underlines the urgent need to develop Usnoflast to address Amyotrophic Lateral Sclerosis (ALS), which is a fatal neurodegenerative disease," said Zydus' ...
NRL legend Mark ‘MG’ Geyer, who was let go from Triple M after 17 years on air, has landed a new high profile radio gig. Geyer has signed a three year deal with 2GB radio in Sydney ...
Thanks for sharing, man! MG Motor India has unveiled the Cyberster at the 2025 Auto Expo. While the electric sportscar was revealed back in 2024, this is the first time it has been showcased in India.
One 97 Communications Paytm, Zomato, APL Apollo Tubes, Central Bank of India, Dixon Technologies, IDBI Bank, Indian Overseas Bank, Indian Railway Finance Corporation, ICICI Securities, Jammu ...
Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its generic version of Paliperidone extended-release tablets, used to treat ...
The multi-centre, placebo-controlled trial aims to enrol 210 subjects with ALS. Credit: David Herraez Calzada / Shutterstock. The US Food and Drug Administration (FDA) has granted approval for Zydus ...
The MG M9 has stolen the spotlight at Auto Expo 2025. With its futuristic design, opulent interiors, and feature-packed cabin, this premium MPV is the epitome of luxury. Let’s dive into the ...
JSW MG Motor India has unveiled two new cars at the Bharat Mobility Global Expo 2025. Introducing the MG Cyberster, India’s first all-electric roadster, and the MG M9, the country’s first ...
The M9 positions MG in the premium electric MPV segment and will be offered exclusively through the brand's 'Select' dealerships MG to retail the premium M9 MPV via its new ‘Select’ dealerships.
Your browser does not support the audio element. JSW MG Motor India has showcased the M9 MPV at the ongoing Auto Expo 2025. This will be the second product sold via ...
The patients received pembrolizumab at 200 mg every 3 weeks plus fulvestrant at 500 mg every 2 weeks for 3 doses, followed by 500 mg every 4 weeks. Staging scans occurred every 3 cycles (9 weeks).